Although there are only about 4000 new cases of amyloidosis in the US per year, it can cause preserved ejection fraction heart failure, kidney and liver failure, and neuropathy. Amyloidosis is easily diagnosed and treatable, and it should be considered in the differential diagnosis for these diseases. Morie A. Gertz, MD, from the Mayo Clinic in Rochester, Minnesota, talks with JAMA Clinical Reviews about amyloidosis.
Related:
Systemic Amyloidosis Recognition, Prognosis, and Therapy
Homelessness and Health Care
USPSTF Recommendation: Interventions to Prevent Falls in Community-Dwelling Older Adults
Treatments to Decrease Severe Respiratory Syncytial Virus (RSV) Illness
Chronic Pruritus
The Federal Trade Commission’s Role in the Oversight of Drug Companies
Financial Incentives for Weight Loss in Men With Obesity
Service Animals in Health Care Settings
USPSTF Recommendation: Screening for Breast Cancer
Diagnosis and Treatment of Interstitial Lung Disease
Clinical Diagnosis of Dislocated Hips in Newborns
Diagnosis and Treatment of Systemic Lupus Erythematosus
Falls in Community-Dwelling Older Adults
Diagnoses and Treatment of Common Oral Conditions
USPSTF Recommendation: Primary Care Interventions to Prevent Child Maltreatment
Arteriovenous Access for Hemodialysis
Diagnosis and Treatment of Allergic Rhinitis
Heart Failure Due to Transthyretin Protein Amyloidosis
Long-Term Outcomes After Bariatric Surgery for Type 2 Diabetes
Diagnosis and Management of Paroxysmal Supraventricular Tachycardia
Prevention and Treatment of Severe Food Allergies
Create your
podcast in
minutes
It is Free
Good Mood Revolution
JAMA Editors’ Summary
JAMA Medical News
JAMAevidence The Rational Clinical Examination
JAMA Psychiatry Author Interviews
JAMA Internal Medicine Author Interviews